<noscript id="w5p92"><object id="w5p92"></object></noscript>

    1. <nav id="w5p92"><code id="w5p92"></code></nav>

      <nav id="w5p92"></nav>
    2. <dd id="w5p92"></dd>
    3. <nav id="w5p92"><optgroup id="w5p92"></optgroup></nav>

        For the latest updates on our ongoing response to COVID-19, please click here.


        Gilead Sciences Russia LLC

        White Gardens
        9 Lesnaya Street
        Moscow 125196 Russia

        Office: +7 495 139 9590 +7 495 139 9590

        Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.

        Read more about Transparency Reporting

        Relationships with Patient Organizations

        Gilead provided support for the following patient organizations in 2019. The information is correct at the time of writing (June 2020). The information is subject to change and periodic updates.

        Recipient Description of Activity Amount Funded RUB
        Supraregional Society Organization on Assitance to Patients "Together Against Hepatitis" Conduct of analysis of the legislation regulating provision of medical aid to patients suffuring from chronic hepatitis infections in Russian regions and preparation of recommendations 550000.00
        Fund to Help People Living with HIV "AIDS.Center" Testing for HIV/HCV, informing and routing of high-risk individuals at the AIDS.Center community center 6204135.00
        Regional Public Organization "AIDS, Statistics, Health" Issue of the magazine "AIDS, SEX, HEALTH" 629780.00
        NGO Humanitarian Project Positive Review Monitoring of HIV and HCV among key groups in Novosibirsk 4815000.00
        Social Partnership Development Fund Purchase of New Year Gifts for Children registered with "Samara Regional Clinical Center for AIDS Prevention and Control" 792220.00

        This page is intended for visitors outside of the United States.